NEXLIZET 180-10 MG TABLET

Bempedoic Acid and Ezetimibe
$13.8411per EA

Strength

180; 10 mg/1; mg/1

NDC

72426081803

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

BEMPEDOIC ACID; EZETIMIBE

Approval Type

New Drug (NDA)

FDA Application

NDA211617

On Market Since

3/9/2020

Pharmacological Classes

Adenosine Triphosphate-Citrate Lyase Inhibitor
Adenosine Triphosphate-Citrate Lyase Inhibitors
Decreased Cholesterol Absorption
Dietary Cholesterol Absorption Inhibitor

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.0%

1Y

+2.9%

3Y

+9.3%

5Y

+23.7%

All

+31.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.